Medpace Holdings, Inc. reported $2.84B of revenue over the trailing twelve months, +20% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.84B (to Q3 2026). Net income: $518M, trailing twelve months to Q3 2026. Free cash flow: $668M, trailing twelve months to Q3 2026. Operating margin: 21%, trailing twelve months to Q3 2026.

MEDPMedpace Holdings, Inc.

Healthcare

$669.27+28% 1Y

$669.27

$393.4252 weeks$669.27

Latest close: a new 52-week highOct 23, 2026what changed →

MEDP as reported

Medpace Holdings, Inc. reported $2.84B of revenue over the trailing twelve months, +20% on the year before. 11 reported series are charted on this page, each one as filed.

$2.84B

Revenue, trailing twelve months · to Q3 2026 · +20% against the twelve months before

Net income: $518M
Net income · +20% year on year · trailing twelve months to Q3 2026
Free cash flow: $668M
Free cash flow · −1.4% year on year · trailing twelve months to Q3 2026
Operating margin: 21%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for MEDP, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.84B	+20%	Q3 2026
Net income	$518M	+20%	Q3 2026
EPS	$18.01	+26%	Q3 2026
Gross margin	29%	n/a	Q3 2026
Operating margin	21%	n/a	Q3 2026
Net margin	18%	n/a	Q3 2026
ROE	94%	n/a	Q3 2026
ROA	23%	n/a	Q3 2026
ROIC	68%	n/a	Q4 2023 · 11 quarters behind
Free cash flow	$668M	−1.4%	Q3 2026
P/E	37.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.